🇺🇸
United States · US · US:54092-474_13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5
MYDAYIS
In shortageOrange BookSPLATC N06BA
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTakeda Pharmaceuticals America, Inc.
CountryUS (United States)
ATC codeN06BA
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc115409247401100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-474-01)
Annotations
Orange Book
N022063
AB2AB2AB2AB2
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Raw payload (JSON)
{
"route": "ORAL",
"spl_meta": {
"141a7970-3f06-44ea-9ab7-aeece2c085fc": {
"match": "brand_token",
"title": "MYDAYIS (DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
"spl_version": "13",
"published_date": "2026-05-06"
}
},
"productid": "54092-474_13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5",
"productndc": "54092-474",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"orange_book": {
"appl_no": "022063",
"products": [
{
"rs": false,
"rld": true,
"te_code": "AB2",
"strength": "3.125MG;3.125MG;3.125MG;3.125MG",
"product_no": "001",
"approval_date": "Jun 20, 2017"
},
{
"rs": false,
"rld": true,
"te_code": "AB2",
"strength": "6.25MG;6.25MG;6.25MG;6.25MG",
"product_no": "002",
"approval_date": "Jun 20, 2017"
},
{
"rs": false,
"rld": true,
"te_code": "AB2",
"strength": "9.375MG;9.375MG;9.375MG;9.375MG",
"product_no": "003",
"approval_date": "Jun 20, 2017"
},
{
"rs": true,
"rld": true,
"te_code": "AB2",
"strength": "12.5MG;12.5MG;12.5MG;12.5MG",
"product_no": "004",
"approval_date": "Jun 20, 2017"
}
],
"appl_type": "N"
},
"dea_schedule": "CII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
"shortage_reason": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
"shortage_status": "current",
"proprietary_name": "MYDAYIS",
"active_ingred_unit": "mg/1; mg/1; mg/1; mg/1",
"application_number": "NDA022063",
"marketing_category": "NDA",
"nonproprietary_name": "DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE",
"start_marketing_date": "20170620",
"active_numerator_strength": "9.375; 9.375; 9.375; 9.375"
}Related drugs
Other records sharing ATC code N06BA.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTakeda Pharmaceuticals America, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
Access this data programmatically
Query MYDAYIS and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.